December 2017
Welcome to the last issue of 2017. This December issue features the annual Innovation Awards, showcasing the year’s 15 best drug development and manufacturing technologies. Upfront covers the road to a universal flu vaccine, continuous techniques for cell therapies, and more. In My View tackles the topics of drug attrition, revolutionizing drug development with bioprinting, and the impact of Brexit. And NextGen revolves around the challenges of creating specialty vaccines, and MVM-resistant CHO cell lines. In addition, we sit down with Richard Markus, Vice President of Global Development at Amgen, to talk about biosimilars.
Mastering Continuous Biomanufacturing-MS
January 3, 2018
With Rickey Lu, Director of Manufacturing Technology Innovation at AstraZeneca.
1 min read
New Horizons-MS
January 3, 2018
A consortium funded by the EU’s Horizon 2020 aims to increase the productivity of biopharma production processes – particularly downstream process development.
1 min read
The Connected Process-MS
January 3, 2018
Connecting processes can be considered the next stage in evolution for biopharma manufacture, but how should companies approach the challenges?
1 min read
Facing the future-MS
January 3, 2018
Why could next generation bioprocessing be so valuable for the biopharma industry? A supplier and a manufacturer share their views.
1 min read
Mastering Continuous Biomanufacturing
January 2, 2018
With Rickey Lu, Director of Manufacturing Technology Innovation at AstraZeneca.
1 min read
New Horizons
January 2, 2018
A consortium funded by the EU’s Horizon 2020 aims to increase the productivity of biopharma production processes – particularly downstream process development.
1 min read
The Connected Process
January 2, 2018
Connecting processes can be considered the next stage in evolution for biopharma manufacture, but how should companies approach the challenges?
1 min read
Facing the future
January 2, 2018
Why could next generation bioprocessing be so valuable for the biopharma industry? A supplier and a manufacturer share their views.
1 min read
Do AIs Dream of Electric R&D?
December 21, 2017
The technology around artificial intelligence is rapidly advancing – and it won’t be long before AI has a significant impact on pharma research and development.
1 min read
Manufacture
Facilities & Equipment
Technology & Manufacturing
Small Molecules
Bioprocessing
Biopharma
Sponsored
The Transformation to Excellence-MS
December 20, 2017
How a customer focused mission to boost single-use assembly product quality and supply security led to the Mobius® MyWay Program and a manufacturing site transformation.
1 min read
Business-in-Brief
December 15, 2017
Addressing the opioid crisis, 3D printing drug guidelines, and execution drugs… What’s new for pharma in business?
1 min read
Breaking Barriers to Biosimilars
December 13, 2017
Sitting Down With… Richard Markus, Vice President of Global Development, Amgen, USA.
1 min read
The Best Defense Is Good Science
December 13, 2017
Starting from fundamental virology, Kevin Kayser and the upstream R&D team at Merck discovered the mechanism by which Minute Virus of Mice (MVM) infects CHO cells, and the respective genes involved in viral uptake.
1 min read
Fantastic Vaccines and Where to Find Them: Lessons Learned with Nima Farzan
December 13, 2017
The field of specialty vaccines can feel underloved, but with growing interest from public health groups, previously under-served diseases may soon have hope.
1 min read
Manufacture
Packaging
Facilities & Equipment
Technology & Manufacturing
Regulation & Standards
Small Molecules
Innovation Strikes Back
December 13, 2017
The Medicine Maker Innovation Awards, now in their third year, celebrate the most exciting drug development and manufacturing technologies of 2017
1 min read
The Problem with Poloxamers
December 13, 2017
Poloxamer 188 has become an essential component of cell culture media, but lot-to-lot variability has been a problem for many biopharma manufacturers. By working with customers directly we’re able to supply a product that can be trusted.
1 min read
How to Cultivate a Quality Mindset
December 13, 2017
Using precise and reliable analytical tools to ensure the successful development and manufacture of your candidate molecule from the outset – and right through to quality control – helps avoid costly pitfalls along the way.
1 min read
Brexit Hits Home
December 13, 2017
It’s all swings and roundabouts in the UK’s life sciences sector with no clear view of what the future holds.
1 min read
Think (Bio)Print
December 13, 2017
Great strides are being made in bioprinting, and the end result could revolutionize pharmaceutical development and testing.
1 min read
De-risking Drug Development
December 13, 2017
Metabolism-based causes of drug attrition must be tackled through intelligent and early risk mitigation strategies.
1 min read
Sharing Is Caring
December 13, 2017
EFPIA and PhRMA team up to promote responsible use of clinical data dissemination
1 min read
Continuing the Trend
December 13, 2017
Continuous processing is being adopted in pharma and biopharma. Could continuous cell therapies be next?
1 min read
Spray It Again, Sam
December 13, 2017
Vapor jet printing of small molecule drugs could have potential in candidate screening – or even delivery
1 min read
Flu Fighters
December 13, 2017
Researchers look to the ancestral genes of influenza to develop a new approach to vaccination
1 min read
